NPR3 and Obesity: Experimental models are required tools to investigate the underlying molecular mechanisms linking the NPR-C pathway, obesity-associated cardiometabolic traits, and HFpEF and to explore the use of potential pharmacological agents in this specific phenotype (Valero-Muñoz et al., 2017; Oh et al., 2019).